Although the decrease in BRCA1 activity upon Cdk1 inhibition was not prominent for combined treatment of RO-3360 and Cisplatin, it is certain that the inhibition of Cdk1 was significantly suppressed cell growth and promoted apoptosis of ovarian cancer cell lines treated with cisplatin. The gene discussed is BRCA1; the disease is ovarian cancer.